Publication: Comparison of single-and mixed-sized gold nanoparticles on lateral flow assay for albumin detection
15
item.page.dc.date.issued
2021-07-01
item.page.dc.type
item.page.dc.identifier.issn
20796374
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-85109418027
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Biosensors. Vol.11, No.7 (2021)
punsarn.item.page.citation
Sasima Chotithammakul, Michael B. Cortie, Dakrong Pissuwan Comparison of single-and mixed-sized gold nanoparticles on lateral flow assay for albumin detection. Biosensors. Vol.11, No.7 (2021). doi:10.3390/bios11070209 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76119
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Comparison of single-and mixed-sized gold nanoparticles on lateral flow assay for albumin detection
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
The sensitivity and reproducibility of the lateral flow assay can be influenced by multiple factors, such as the size of gold nanoparticles (GNPs) employed. Here, we evaluated the analytical performance of single-sized and mixed-sized GNPs using a simple lateral flow assay (LFA) platform. This platform was used as a model assay to diagnose albumin levels and demonstrate the analytical performance of single-sized and mixed-sized GNPs in LFA tests. Two sizes of GNPs@anti-bovine serum albumin (BSA) conjugate proteins were mixed at different ratios. The unique optical properties of the GNPs induced a distinguishing color-shedding effect on the single-and mixed-sized GNPs@anti-BSA conjugates interacting with the target analyte BSA spotted on the test line. The use of mixed-sized GNPs@anti-BSA conjugates enhanced signal relative to the 20 nm GNPs, and provided superior stability compared with solely employing the large GNPs (50 nm). The proposed platform in this study could provide an efficient BSA detection mechanism that can be utilized as a model biomarker for confronting chronic kidney disease.